HCL Partners With Visiprise to Provide Professional Services to Global Manufacturers in the Medical Device Industry

SUNNYVALE, CA and NOIDA, INDIA, Jan 22 (MARKET WIRE)
--
HCL Technologies Ltd. ("HCL"), leading global IT services company, has
entered into a global consulting partnership with Visiprise, Inc. for the Life
Sciences industry, covering all aspects of the medical device manufacturing
cycle.
Visipriseprovides manufacturing execution solutions (MES) that help global
manufacturers
to gain visibility into operations, achieve shop floor control and manage
product and process traceability. The consulting agreement will include joint
marketing, sales and pre-sales services and will result in the ability for
seamless licensing, blueprinting, implementation, plant-business integration,
roll-out,
support, upgrade / migration and instance consolidation services to
manufacturers.

The strategic partnership will further strengthen HCL's position as
"innovators/leaders" in the Manufacturing IT landscape with initial focus on
medical devices further expanding to Hitech, Aerospace, Auto and other discrete
industries. Under this agreement Visiprise will also be training and certifying
HCL consultants on Visiprise solutions.

Speaking on the occasion Mr. Pradep Nair, VP, Global Life Sciences and
Healthcare practice, HCL Technologies, said, "With increasing global
competition, it is imperative for manufacturers to innovate faster, cheaper,
with
sustained/better quality meeting stringent regulatory norms. Manufacturers are
therefore making strategic investments in comprehensive IT solutions focused
towards
improving efficiency in the plant operations and increasing collaboration
between
engineering, enterprise and plant functions as well as extended eco systems
such as partners and suppliers. HCL's partnership with Visiprise is well poised
in
bringing about the transformational change in plant operations. We believe
that Visiprise's technology and strategic alignment with SAP and PLM vendors
will help
customers in seamless business integration from shop-floor to top-floor, which
aligns well with HCL's focus towards Manufacturing IT solutions and services."

"HCL's focus in medical devices, coupled with their comprehensive approach
in
providing total plant-level IT aligns well with our vision of delivering a total
manufacturing solution for the integrated enterprise," said Mike Lacky, Vice
President of industry business units from Visiprise. "HCL Technologies has a
global footprint and a proven ability to deliver solutions in a complex,
manufacturing environment."

Commenting on the partnership, Ralph Rio, Director ARC Advisory, remarks,
"Among
the discrete industries, the competitive landscape today demands a speed of
execution that is driving the adoption of MES applications like Visiprise. In
addition, electronic records provided by MES applications are needed for
compliance
with US FDA regulations. Our research shows rapid MES market growth that
recently reached 27% year-to-year. The HCL and Visiprise partnership helps
fill this major market opportunity with software and support for the lifecycle
of a MES project." The ARC Advisory Group is a leading research, advisory firm
and
the thought leaders in manufacturing, logistics and supply chain solutions.

About Visiprise, Inc.

Visiprise is a leading provider of manufacturing execution for integrated
manufacturing operations. Visiprise helps manufacturers gain visibility into
manufacturing operations, achieve shop floor control and manage product and
process traceability. Focused on aerospace and defense, high tech, automotive,
and medical device industries, more than 200 customers around the globe turn to
Visiprise. Customers include Actia, BAE Systems, Celestica, ConMed, E-Z-GO
Textron, Lockheed Martin, Philips Lighting, Solectron and Thales Avionics. For
more
information, visit www.visiprise.com.

About HCL's Life Sciences & Healthcare Practice

The Life Sciences & Healthcare practice at HCL delivers IT centric solutions
across the pharmaceutical, medical device and hospital industries. The DNA of
the
practice lies in extension of this knowledge to provide focused IT services
and solutions to the customers. HCL's investments have strong focus on
regulatory compliance prescribed by the FDA's CFR, CEC, ISO, HIPAA and
meeting technology paradigms surrounding HL7, DICOM, and others. HCL continues
to
invest in providing tested solutions in arenas such as Pharmacogenomics, medical
devices and diagnostics, contract manufacturing, and hospital information
systems. The Life Sciences & Healthcare team comprises 1500 consultants,
includingregulatory experts, bio technologists and pharmaceutical industry
experts.

About HCL Technologies

HCL Technologies is one of India's leading global IT Services companies,
providing
software-led IT solutions, remote infrastructure management services and BPO.
Having
made a foray into the global IT landscape in 1999 after its IPO, HCL
Technologies focuses on Transformational Outsourcing, working with clients in
areas
that impact and re-define the core of their business. The company leverages an
extensive global offshore infrastructure and its global network of offices in 18
countries to deliver solutions across select verticals including Financial
Services, Retail & Consumer, Life Sciences & Healthcare, Hi-Tech &
Manufacturing,
Telecom and Media & Entertainment (M&E). For the quarter ended 30th
September 2007, HCL Technologies, along with its subsidiaries had last twelve
months (LTM) revenue of US $ 1.6 billion (Rs. 6715 crores) and employed 47,954
professionals. For more information, please visit www.hcltech.com

About HCL Enterprise

HCL Enterprise is a $4.5 billion (Rs. 18,877 crore) leading Global
Technology
and IT enterprise that comprises two companies listed in India - HCL
Technologies & HCL Infosystems. The 3-decade-old enterprise, founded in
1976, is one of India's original IT garage start-ups. Its range of offerings
span Product Engineering, Custom & Package Applications, BPO, IT
Infrastructure Services, IT Hardware, Systems Integration, and
distributionof ICT products. The HCL team comprises approximately 53,000
professionals of diverse
nationalities, who operate from 18 countries including 360 points of presence
in India. HCL has global partnerships with several leading Fortune 1000 firms,
including leading IT and Technology firms. For more information, please visit
www.hcl.in

Forward-looking Statements

Certain statements in this release are forward-looking statements, which
involve a number of risks, uncertainties, assumptions and other factors that
could cause actual results to differ materially from those in such
forward-looking statements. All statements, other than statements of
historical fact are statements that could be deemed forward-looking statements,
including
but not limited to the statements containing the words 'planned,' 'expects,'
'believes,' 'strategy,' 'opportunity,' 'anticipates,' 'hopes' or other similar
words.
The risks and uncertainties relating to these statements include, but are not
limited
to, risks and uncertainties regarding impact of pending regulatory
proceedings,fluctuations in earnings, our ability to manage growth, intense
competitionin IT services, Business Process Outsourcing and consulting services
including
those factors which may affect our cost advantage, wage increases in India,
customer acceptances of our services, products and fee structures, our
ability to attract and retain highly skilled professionals, our ability to
integrate
acquired assets in a cost effective and timely manner, time and cost overruns on
fixed-price, fixed-time frame contracts, client concentration, restrictions on
immigration, our ability to manage our international operations, reduced demand
for technology in our key focus areas, disruptions in telecommunication
networks, our ability to successfully complete and integrate potential
acquisitions, the success of our brand development efforts, liability for
damages on our service contracts, the success of the companies /entities in
which
we have made strategic investments, withdrawal of governmental fiscal
incentives,political instability, legal restrictions on raising capital or
acquiring companies
outside India, and unauthorized use of our intellectual property, other risks,
uncertainties and general economic conditions affecting our industry. There
can be no assurance that the forward-looking statements made herein will prove
to be
accurate, and issuance of such forward-looking statements should not be regarded
as a
representation by the Company, or any other person, that the objective and
plans of the Company will be achieved. All forward-looking statements made
herein are based on information presently available to the management of the
Company and the Company does not undertake to update any forward-looking
statement that may be made from time to time by or on behalf of the Company.

For details, contact

HCL
Geetanjali Bhatia
+91 9811987765
Email Contact

Citigate Cunningham
Sandy Dawkins
617-374-4243
Email Contact

Copyright 2008, Market Wire, All rights reserved.

-0-